H.U. Group Holdings Past Earnings Performance
Past criteria checks 0/6
H.U. Group Holdings's earnings have been declining at an average annual rate of -3.5%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 6.8% per year.
Key information
-3.5%
Earnings growth rate
-3.5%
EPS growth rate
Healthcare Industry Growth | 7.9% |
Revenue growth rate | 6.8% |
Return on equity | -4.4% |
Net Margin | -2.6% |
Next Earnings Update | 08 Nov 2024 |
Recent past performance updates
Recent updates
H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00
Sep 25H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00
Sep 04H.U. Group Holdings (TSE:4544) Is Due To Pay A Dividend Of ¥62.00
Aug 21Estimating The Fair Value Of H.U. Group Holdings, Inc. (TSE:4544)
Aug 20H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00
Jul 26H.U. Group Holdings' (TSE:4544) Dividend Will Be ¥62.00
Jul 11Analysts Have Been Trimming Their H.U. Group Holdings, Inc. (TSE:4544) Price Target After Its Latest Report
Jun 24Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?
Jun 21H.U. Group Holdings, Inc.'s (TSE:4544) Intrinsic Value Is Potentially 54% Above Its Share Price
Feb 28Revenue & Expenses Breakdown
How H.U. Group Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 239,797 | -6,258 | 49,421 | 11,262 |
31 Mar 24 | 236,950 | -7,553 | 50,046 | 11,262 |
31 Dec 23 | 237,456 | -6,458 | 52,055 | 9,556 |
30 Sep 23 | 243,370 | -1,699 | 52,165 | 9,556 |
30 Jun 23 | 252,197 | 8,969 | 51,944 | 9,556 |
31 Mar 23 | 260,908 | 15,676 | 51,572 | 9,556 |
31 Dec 22 | 276,026 | 22,870 | 56,921 | 7,281 |
30 Sep 22 | 273,286 | 25,633 | 55,780 | 7,281 |
30 Jun 22 | 274,783 | 26,843 | 54,370 | 7,281 |
31 Mar 22 | 272,944 | 29,599 | 51,184 | 7,281 |
31 Dec 21 | 259,808 | 30,266 | 48,701 | 5,944 |
30 Sep 21 | 258,189 | 31,885 | 46,483 | 5,944 |
30 Jun 21 | 242,604 | 27,194 | 43,795 | 5,944 |
31 Mar 21 | 223,016 | 17,468 | 42,090 | 5,944 |
31 Dec 20 | 207,955 | 9,077 | 40,513 | 5,514 |
30 Sep 20 | 193,798 | 2,042 | 39,230 | 5,514 |
30 Jun 20 | 186,332 | -3,054 | 39,182 | 5,514 |
31 Mar 20 | 188,712 | -516 | 39,421 | 5,514 |
31 Dec 19 | 188,014 | 2,733 | 39,142 | 5,937 |
30 Sep 19 | 185,231 | 4,457 | 38,290 | 5,937 |
30 Jun 19 | 182,727 | 5,697 | 38,028 | 5,937 |
31 Mar 19 | 181,415 | 6,386 | 38,900 | 5,937 |
31 Dec 18 | 178,473 | 886 | 38,453 | 5,365 |
30 Sep 18 | 181,159 | 9,801 | 41,683 | 5,365 |
30 Jun 18 | 188,204 | -2,499 | 43,967 | 5,365 |
31 Mar 18 | 195,400 | 257 | 45,081 | 5,365 |
31 Dec 17 | 202,563 | 6,272 | 44,774 | 4,748 |
30 Sep 17 | 205,497 | 359 | 42,628 | 4,748 |
30 Jun 17 | 204,346 | 2,948 | 41,007 | 4,748 |
31 Mar 17 | 204,245 | 333 | 40,603 | 4,748 |
31 Dec 16 | 206,217 | 5,091 | 38,572 | 5,702 |
30 Sep 16 | 208,413 | -16,703 | 39,755 | 5,702 |
30 Jun 16 | 211,076 | -7,065 | 41,333 | 5,702 |
31 Mar 16 | 211,743 | -5,081 | 41,878 | 5,702 |
31 Dec 15 | 209,940 | -7,471 | 41,747 | 5,384 |
30 Sep 15 | 208,432 | 14,365 | 41,694 | 5,384 |
30 Jun 15 | 206,193 | 16,713 | 40,687 | 5,384 |
31 Mar 15 | 204,667 | 16,002 | 40,047 | 5,384 |
31 Dec 14 | 204,911 | 16,454 | 41,518 | 5,412 |
30 Sep 14 | 204,342 | 14,813 | 42,402 | 5,412 |
30 Jun 14 | 203,997 | 14,350 | 43,085 | 5,412 |
31 Mar 14 | 203,371 | 15,322 | 43,351 | 5,412 |
31 Dec 13 | 200,277 | 15,391 | 43,295 | 5,077 |
Quality Earnings: 4544 is currently unprofitable.
Growing Profit Margin: 4544 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4544 is unprofitable, and losses have increased over the past 5 years at a rate of 3.5% per year.
Accelerating Growth: Unable to compare 4544's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 4544 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.6%).
Return on Equity
High ROE: 4544 has a negative Return on Equity (-4.37%), as it is currently unprofitable.